Offer - Urjas Oil for just ₹ 1
Rasipar 0.5 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Parkinson's Disease.
The correct dosage of Rasipar 0.5 Mg Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Rasipar 0.5 Mg Tablet can also lead to other problems, which have been listed below. Such side effects of Rasipar 0.5 Mg Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Rasipar 0.5 Mg Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on Rasipar 0.5 Mg Tablet related warnings talks about Rasipar 0.5 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Psychosis, Low Blood Pressure (Hypotension) must refrain from the use of Rasipar 0.5 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Rasipar 0.5 Mg Tablet are listed in the contraindications section below.
Besides this, Rasipar 0.5 Mg Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Rasipar 0.5 Mg Tablet is not safe while driving, and is is not addictive in nature.
Rasipar 0.5 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Rasipar 0.5 Mg Tablet safe for pregnant women?
Rasipar can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Rasipar right away. Take your doctor's advice before taking it again.
Is the use of Rasipar 0.5 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Rasipar. So it is adviced to consult the doctor before using it.
What is the effect of Rasipar 0.5 Mg Tablet on the Kidneys?
Rasipar has very mild side effects on the kidneys.
What is the effect of Rasipar 0.5 Mg Tablet on the Liver?
Rasipar has very mild side effects on the liver.
What is the effect of Rasipar 0.5 Mg Tablet on the Heart?
There are no any side effects of Rasipar for the heart.
If you are suffering from any of the following diseases, you should not take Rasipar 0.5 Mg Tablet unless your doctor advises you to do so -
Is this Rasipar 0.5 Mg Tablet habit forming or addictive?
No, there is no any evidence that Rasipar 0.5 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rasipar 0.5 Mg Tablet, you should not drive or work on any heavy machine, as Rasipar 0.5 Mg Tablet can make you drowsy.
Is it safe?
Rasipar 0.5 Mg Tablet is safe as it does not bear any side effects.
Is it able to treat mental disorders?
Rasipar 0.5 Mg Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Rasipar 0.5 Mg Tablet
Eating certain foods may increase the time it takes Rasipar 0.5 Mg Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Rasipar 0.5 Mg Tablet
Taking alcohol with Rasipar 0.5 Mg Tablet can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Azilect (rasagiline mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 432
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1085-1086
